Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Nebulized Magnesium Sulphate in Terms of In-hospital Outcome of Patients Admitted With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

NCT05699720 is registered in ClinicalTrials.gov with King Edward Medical University as lead sponsor.

NCT NCT05699720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05699720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Nebulized Magnesium Sulphate in Terms of In-hospital Outcome of Patients Admitted With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Lead sponsor
King Edward Medical University
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2019
Completion date
December 31, 2020
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease exacerbation, magnesium sulfate